The devastating effects of fatty liver on heart and kidney health have been proven.

It has been proven that fatty liver disease, which affects one in every three adults worldwide and is known as "metabolic dysfunction-associated steatotic liver disease" (MASLD) in the medical literature, is not limited to a single organ, contrary to popular belief. The massive review, jointly conducted by researchers at the University of Manchester and Northern Care Alliance NHS Foundation and published in the journal Current Opinion in Nephrology and Hypertension, documented the devastating effects of fatty liver on heart and kidney health. In the study where data from millions of patients were examined, it was determined that fatty liver triggered heart attack and chronic kidney failure, independent of diabetes, hypertension and obesity.

"CRHM SYNDROME": DANGEROUS INTER-ORGAN CONNECTION HAS BEEN DISSOLVED

Scientists; Stating that the heart, kidney, liver and metabolic system cannot be considered separately from each other, he puts this organ chain into a new medical framework called "Cardiovascular-Renal-Hepatic-Metabolic (CRHM) Syndrome".

Researchers state that the fatty liver secretes inflammatory substances into the bloodstream, and that this condition disrupts the vascular structure, disrupts the body's energy balance and directly regresses kidney functions. When hardening (fibrosis) develops in the liver, the risk of early death increases to the highest level.

2040 WARNING: IT WILL AFFECT MORE THAN HALF OF THE ADULT POPULATION

Clinical data show that fatty liver disease is one of the fastest-growing health problems in the world and will affect more than half of the global adult population by 2040.

One of the experts conducting the research, Dr. "For many years, we have viewed heart, kidney and liver diseases as independent processes managed by different specialists. However, evidence proves that these organs are deeply interconnected through insulin resistance, obesity and chronic inflammation. Fatty liver is not just a consequence of poor metabolism, it is an active factor that directly disrupts it," said Will Marshall.

SLIMMING AND DIABETES DRUGS OPEN A NEW PAGE IN ORGAN PROTECTION

The research also drew attention to a pleasing development in stopping this destruction in the organ chain. It has been documented that new generation active ingredients, originally developed for the treatment of Type 2 diabetes and obesity, provide simultaneous protection on the liver, heart and kidney.

Researchers stated that drugs containing the active ingredient semaglutide are the first successful option in reversing organ damage; He explained that new molecules such as tirzepatide and retatrutide also showed promising results in clinical trials. Experts call on the medical world that routine liver scans should be made mandatory in cardiology and nephrology examinations.